INS and diabetes mellitus: Recently, a novel non–insulin-based substitute of IR combining glucose and lipid metabolism and body fat components was developed, called METS‐IR, which has been proven to be superior to the TyG index and TG/HDL-C in the diagnosis of diabetes [20], which was basically consistent with our main findings; that is, METS-IR might be superior to TyG and TG/HDL-C in the diagnosis of CAC.